A PHASE 2 OPEN-LABEL STUDY OF STA-9090 FOR PATIENTS WITH METASTATIC BREAST CANCER.
Phase of Trial: Phase II
Latest Information Update: 24 Nov 2015
At a glance
- Drugs Ganetespib (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 26 Sep 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 08 Dec 2011 Results were presented at the 2011 San Antonio Breast Cancer Symposium, according to a Synta Pharmaceuticals media release. They were also reported in the media release.
- 04 Nov 2011 Results will be presented at the 2011 San Antonio Breast Cancer Symposium (SABCS).